SCHEMBL4245305

SCHEMBL4245305

CSc1ccc(NC(=N)N)nc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 1/20 0.42
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 2/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 4/20 0.39
NPC1 O15118 4/20 0.39
MITF O75030 1/20 0.39
NSD2 O96028 1/20 0.37
MAPT P10636 2/20 0.36
NOS3 P29474 2/20 0.34
NOS1 P29475 2/20 0.34
PTK2 Q05397 1/20 0.34
IDO1 P14902 1/20 0.34
NNMT P40261 1/20 0.34
ADRA2A P08913 3/20 0.34
ADRA2B P18089 3/20 0.34
ADRA2C P18825 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30421111 0.77 PTK2 (0.59) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL29557349 0.77 RAB9A (0.61) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL6577999 0.77 RAB9A (0.61) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL23845465 0.76 KDM4E (0.41) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL19173050 0.74 PTGS1 (0.47) L3MBTL1RAB9AMAPTPTK2NNMT
SCHEMBL4248528 0.74 HCAR3 (0.46) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL19151378 0.73 ADORA3 (0.53) MEN1KMT2AALDH1A1HTTL3MBTL1
SCHEMBL4656608 0.73 RAB9A (0.35) L3MBTL1RAB9ANPC1MAPTPTK2
SCHEMBL22583226 0.73 PRMT1 (0.41) KMT2AKDM4ENOS3NOS1IDO1
Hydrochloric Acid SCHEMBL7244962 0.73 PTGS1 (0.46) L3MBTL1RAB9ANPC1MAPTPTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233928-A1 IMIDAZOLO-5-YL-2-ANILO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION ASTRAZENECA AB (SE) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233928-A1 IMIDAZOLO-5-YL-2-ANILO-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELL PROLIFERATION MKI67, TYMP, PCNA MEN1 1784/4885KMT2A 2751/4885ALDH1A1 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.